Domusdx
1 known investors
Domus Diagnostics develops low-cost diagnostic tests for infectious diseases using RT-LAMP nucleic acid chemistry combined with simple manufacturing, targeting at-home, point-of-care, and central laboratory testing. The company aims to deliver PCR-level accuracy with results in 30 minutes or less for use across global markets.